Ketorolac Suppresses Postoperative Bladder Spasms After Pediatric Ureteral Reimplantation
Authors:
- John M. ParkJPJohn M. Park
- Constance S. HouckCHConstance S. Houck
- Navil F. SethnaNSNavil F. Sethna
- Lorna J. SullivanLSLorna J. Sullivan
- Anthony AtalaAAAnthony Atala
- Joseph G. BorerJBJoseph G. Borer
- Bartley G. CilentoBCBartley G. Cilento
- David A. DiamondDDDavid A. Diamond
- Craig A. PetersCPCraig A. Peters
- Alan B. RetikARAlan B. Retik
- Stuart B. BauerSBStuart B. Bauer
- 1 July 2000
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 91 (1) , 11-15
Abstract
D randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy. Implications We studied the efficacy of ketorolac, a prostaglandin synthesis inhibitor, in the treatment of bladder spasm after ureteroneocystostomy (antireflux operation). Patients were randomized in a double-blinded manner to receive either ketorolac or placebo after the surgery. We demonstrate that ketorolac reduces the frequency and severity of postoperative bladder spasm....Keywords
This publication has 12 references indexed in Scilit:
- Desensitization of Bladder Sensory Fibers by Intravesical Capsaicin has Long Lasting Clinical and Urodynamic Effects in Patients With Hyperactive or Hypersensitive Bladder DysfunctionJournal of Urology, 1997
- Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing systemThe Journal of Pediatrics, 1996
- Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors.Proceedings of the National Academy of Sciences, 1996
- Outcome Study of Patient-Controlled Morphine Analgesia, With or Without Ketorolac, Following Radical Retropubic ProstatectomyJournal of Urology, 1995
- Intravenous ketorolac as an adjuvant to pediatric patient-controlled analgesia with morphineJournal of Clinical Anesthesia, 1994
- Prostanoids as local modulators of reflex micturitionPharmacological Research, 1992
- Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferentsEuropean Journal of Pharmacology, 1988
- The morphine sparing effect of ketorolac tromethamineAnaesthesia, 1987
- Urinary Bladder Prostanoids—Their Synthesis, Function and possible Role in the Pathogenesis and Treatment of DiseaseJournal of Urology, 1987
- The Effect of Cyclooxygenase Inhibitors on the Low Filling Rate Cystometrogram in Urethane Anesthetized RatsJournal of Urology, 1985